Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
DexCom Inc (DXCM)  
$128.37 1.72 (1.36%) as of 4:30 Fri 5/3


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 389,580,000
Market Cap: 50.01(B)
Last Volume: 1,778,975 Avg Vol: 1,913,734
52 Week Range: $75.49 - $140.45
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:

    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  487
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   DexCom is a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems. Co.'s product candidates include Dexcom G7®, which is designed with the goal of carrying forward many of the same features as Co.'s G6 CGM system and adding several new or improved features. Co.'s products include: DexCom G6® integrated Continuous Glucose Monitoring System (G6), which is a type of CGM system to be used as part of an integrated system with other medical devices and electronic interfaces; and DexCom Share®, which transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 214,480 283,298 303,316 571,262
Total Sell Value $28,881,982 $37,155,070 $39,545,240 $69,827,197
Total People Sold 7 12 14 16
Total Sell Transactions 14 29 47 80
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 1713
  Page 6 of 69  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Leach Jacob Steven EVP Chief Technology Officer   •       –      –    2023-03-08 4 A $0.00 $25 D/D 25,397 306,486     -
   Lawver Teri L EVP Chief Commercial Officer   •       –      –    2023-03-08 4 A $0.00 $45 D/D 45,352 45,352     -
   Selvaraj Shelly Ramasamy SVP Chief Information Officer   •       –      –    2023-03-08 4 A $0.00 $11 D/D 10,885 60,984     -
   Pacelli Steven Robert EVP Managing Director Dexcom V   •       –      –    2023-03-08 4 A $0.00 $19 D/D 18,776 155,240     -
   Regan Barry J. EVP Operations   •       –      –    2023-03-08 4 A $0.00 $19 D/D 18,776 78,162     -
   Stern Sadie EVP Chief Human Resources Offi   •       –      –    2023-03-08 4 A $0.00 $22 D/D 21,769 90,153     -
   Dolan Matthew Vincent SVP Corporate Strategy-Develop   •       –      –    2023-03-08 4 A $0.00 $22 D/D 21,769 48,305     -
   Brown Micheal Jon EVP Chief Legal Officer   •       –      –    2023-03-08 4 A $0.00 $22 D/D 21,769 70,294     -
   Leach Jacob Steven EVP Chief Technology Officer   •       –      –    2023-03-06 4 AS $114.45 $2,081,822 D/D (18,144) 281,089 21%     
   Dolan Matthew Vincent SVP Corporate Strategy-Develop   •       –      –    2023-03-06 4 AS $114.40 $25,854 D/D (226) 26,536 21%     
   Sayer Kevin R President CEO and Chairman of   •       •      –    2023-03-01 4 AS $109.83 $4,228,611 D/D (38,464) 331,337 18%     
   Pacelli Steven Robert EVP Managing Director Dexcom V   •       –      –    2023-02-23 4 AS $111.64 $45,996 D/D (412) 136,464 14%     
   Sylvain Jereme M EVP Chief Financial Officer   •       –      –    2023-02-22 4 AS $114.54 $274,896 D/D (2,400) 64,837 14%     
   Regan Barry J. EVP Operations   •       –      –    2023-01-30 4 AS $106.12 $234,844 D/D (2,213) 59,386 15%     
   Sayer Kevin R President CEO and Chairman of   •       •      –    2023-01-30 4 AS $106.06 $6,034,123 D/D (56,844) 369,801 15%     
   Pacelli Steven Robert EVP Managing Director Dexcom V   •       –      –    2023-01-23 4 AS $107.86 $44,438 D/D (412) 136,876 12%     
   Sayer Kevin R President CEO and Chairman of   •       •      –    2023-01-20 4 S $105.75 $4,822,872 D/D (45,607) 426,645 -9%     
   Sayer Kevin R President CEO and Chairman of   •       •      –    2023-01-18 4 A $0.00 $0 D/D 90,720 472,252     -
   Pacelli Steven Robert EVP Managing Director Dexcom V   •       –      –    2022-12-23 4 AS $112.57 $46,379 D/D (412) 137,288 8%     
   Flynn Paul R EVP Global Revenue   •       –      –    2022-12-08 4 AS $123.50 $1,110,018 D/D (8,988) 55,744 -0%     
   Regan Barry J. EVP Operations   •       –      –    2022-11-21 4 D $112.62 $425,818 D/D (3,781) 61,599     -
   Sylvain Jereme M EVP Chief Financial Officer   •       –      –    2022-11-21 4 AS $112.62 $270,288 D/D (2,400) 67,237 3%     
   Stern Sadie EVP Chief Human Resources Offi   •       –      –    2022-11-21 4 D $112.62 $432,911 D/D (3,844) 68,384     -
   Naganathan Girish EVP Chief Technology Officer   •       –      –    2022-11-08 4 A $0.00 $31 D/D 31,449 31,449     -
   Sayer Kevin R President CEO and Chairman of   •       •      –    2022-11-03 4 GD $0.00 $0 D/D 10,000 381,532     -

  1713 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 6 of 69
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed